trimebutine has been researched along with Pancreatitis, Chronic in 1 studies
Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.
Pancreatitis, Chronic: INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lembrik, IS | 1 |
1 other study available for trimebutine and Pancreatitis, Chronic
| Article | Year |
|---|---|
[Effectiveness of treatment of pancreatic disorders in children (based on catamnesis)].
Topics: Adolescent; C-Peptide; Child; Feces; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Mal | 2013 |